ArticleJournal of experimental & clinical cancer research : CR2021

MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.

Xu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.